Request Deal Involvement

Novartis Venture Fund and Forbion led a $130m Series B funding round in Protego Biopharma.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

The Grace Communication Group

pr advisors

The Grace Communication Group

Cooley

legal advisors

Cooley

or

Principals

PROTEGO BIOPHARMA INC

target

PROTEGO BIOPHARMA INC

NOVARTIS VENTURE FUND

bidder

NOVARTIS VENTURE FUND

FORBION CAPITAL PARTNERS

bidder

FORBION CAPITAL PARTNERS

OMEGA FUNDS

bidder

OMEGA FUNDS

DROIA VENTURES

bidder

DROIA VENTURES

YK BIOVENTURES

bidder

YK BIOVENTURES

DIGITALIS VENTURES

bidder

DIGITALIS VENTURES

VIDA VENTURES

bidder

VIDA VENTURES

MPM BIOIMPACT

bidder

MPM BIOIMPACT

LIGHTSPEED VENTURE PARTNERS

bidder

LIGHTSPEED VENTURE PARTNERS

SCRIPPS RESEARCH

bidder

SCRIPPS RESEARCH

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2026 Datasite

MergerLinks - Request Credit - Novartis Venture Fund and Forbion led a $130m Series B funding round in Protego Biopharma.